Certara welcomes Rose Crane to its Board as Independent Director
– USA, NJ – Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Rose Crane to its Board as an Independent Director, effective July 21, 2022, bringing the board to eleven members.…